Dr Samir DevaniSamir joined Nomura Code Securities in 2003 and has 10 years experience covering the biotechnology sector. He has previously worked at JP Morgan, Numis Securities and Altium Capital. In 2003, Samir was awarded a 5 Star Starmine ranking in Extel’s Pan European biotechnology survey. In 2002 he was ranked 10th both in the Extel and the Institutional Investor pan-European institutional investor surveys. Samir is a registered pharmacist and completed a degree in Pharmacy at London University’s School of Pharmacy and a PhD in pharmaceutical technology at King’s College London. He is also a member of the Association of Investment Management Research.
T +44 (0)20 7776 1244 |
COPYRIGHT (C) 1996-2010 NOMURA HOLDINGS, INC. ALL RIGHTS RESERVED
Nomura Code Securities Limited is a company registered in England and Wales, no. 4778512 and controls this Site. Nomura Code Securities is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange. Registered Office: 1 Carey Lane, London, EC2V 8AE.
Nomura Code Securities Limited is a company registered in England and Wales, no. 4778512 and controls this Site. Nomura Code Securities is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange. Registered Office: 1 Carey Lane, London, EC2V 8AE.